Urology Laser Market Segmentation:
Application Segment Analysis
The benign prostatic hyperplasia segment is expected to garner the highest share of 45.7% in the urology laser market by the end of 2035. The dominance of the segment is attributable to the increasing occurrence of benign prostatic hyperplasia among the male population across all nations. In this context, the preference for laser therapies such as thulium and holmium lasers is on the rise due to their tremendous effectiveness and reduced complication rates when compared to traditional surgical methods. Besides the adoption of minimally invasive procedures, this further heightens the demand for these treatments.
Laser Type Segment Analysis
Thulium laser system segment is projected to hold the second-largest share of 35.4% in the market during the forecast timeline. The growth in the segment is subject to its enhanced efficacy in treating urological conditions. Besides this, the thulium lasers offer remarkable benefits such as lower bleeding rates and fast tissue resection speeds, making them ideal for procedures such as prostate enucleation. In addition, the growing elderly population also majorly contributes to the segment’s growth.
End User Segment Analysis
Hospitals define an essential portion of this market. Hospitals had a significant share of the market because they can offer many services, including comprehensive urology laser, from initial consultation with a urologist to intravenous urography and percutaneous nephrolithotomy with the latest laser technologies. In the hospital setting, sophisticated laser systems allow urologists to perform advanced techniques. By using advanced laser technologies, patients now benefit from minimally invasive treatment modalities, in which they receive their care in an acute care environment with faster recovery times.
Our in-depth analysis of the global market includes the following segments:
|
Segments |
Subsegments |
|
Laser Type |
|
|
End user |
|
|
Application |
|
